These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24993329)

  • 21. Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: The Princess Margaret experience and proposal.
    Huang SH; O'Sullivan B; Su J; Ringash J; Bratman SV; Kim J; Hosni A; Bayley A; Cho J; Giuliani M; Hope A; Spreafico A; Hansen AR; Siu LL; Gilbert R; Irish JC; Goldstein D; de Almeida J; Tong L; Xu W; Waldron J
    Cancer; 2020 Aug; 126(15):3426-3437. PubMed ID: 32478895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-dose reirradiation with intensity-modulated radiotherapy for recurrent head-and-neck cancer: disease control, survival and toxicity.
    Duprez F; Berwouts D; Madani I; Bonte K; Boterberg T; De Gersem W; Deron P; Huvenne W; De Neve W
    Radiother Oncol; 2014 Jun; 111(3):388-92. PubMed ID: 24998706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.
    Ye AY; Hay JH; Laskin JJ; Wu JS; Ho CC
    J Cancer Res Ther; 2013; 9(4):607-12. PubMed ID: 24518704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
    Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
    Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypopharyngeal squamous cell carcinoma: Three-dimensional or Intensity-modulated radiotherapy? A single institution's experience.
    Katsoulakis E; Riaz N; Hu M; Morris L; Sherman E; McBride S; Lee N
    Laryngoscope; 2016 Mar; 126(3):620-6. PubMed ID: 26597398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pattern of failure after reirradiation of recurrent squamous cell head and neck cancer: implications for defining the targets.
    Popovtzer A; Gluck I; Chepeha DB; Teknos TN; Moyer JS; Prince ME; Bradford CR; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1342-7. PubMed ID: 19135312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience.
    Akbaba S; Held T; Lang K; Hoerner-Rieber J; Zaoui K; Forster T; Rieken S; Plinkert P; Debus J; Adeberg S
    Radiat Oncol; 2019 Feb; 14(1):34. PubMed ID: 30782197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reirradiation for recurrent head and neck carcinoma.
    Peponi E; Balta S; Tasiou I; Gogou P; Capizzello A; Pitouli E; Tsekeris P
    J BUON; 2012; 17(3):465-70. PubMed ID: 23033283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Re-irradiation versus systemic therapy for the management of local-regionally recurrent head and neck cancer.
    Chen AM; Harris JP; Nabar R; Tjoa T; Haidar Y; Armstrong WB
    Radiother Oncol; 2024 Jul; 196():110278. PubMed ID: 38636710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individualized treatment of head neck squamous cell carcinoma patients aged 70 or older with radiotherapy alone or associated to cisplatin or cetuximab: impact of weekly radiation dose on loco-regional control.
    Belgioia L; Bacigalupo A; Missale F; Vecchio S; Chiola I; Callegari S; Verzanini E; Peretti G; Corvò R
    Med Oncol; 2019 Mar; 36(5):42. PubMed ID: 30927146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modified fractionated radiotherapy in head and neck squamous cell carcinoma (HNSCC) & re-irradiation in recurrent head and neck carcinomas.
    De Crevoisier R; Bourhis J; Eschwège F
    Cancer Treat Res; 2003; 114():199-212. PubMed ID: 12619542
    [No Abstract]   [Full Text] [Related]  

  • 32. [Intensity-modulated radiation therapy for head and neck cancers with bilateral irradiation of the neck : preliminary results].
    Lapeyre M; Marchesi V; Mege A; Aletti P; Graff P; Racadot S; Noel A; Marchal C
    Cancer Radiother; 2004 Jun; 8(3):134-47. PubMed ID: 15217581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemo-reirradiation in persistent/recurrent head and neck cancers.
    Nagar YS; Singh S; Datta NR
    Jpn J Clin Oncol; 2004 Feb; 34(2):61-8. PubMed ID: 15067097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
    Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reirradiation with IMRT for recurrent head and neck cancer: A single-institutional report on disease control, survival, and toxicity.
    Ahlawat P; Rawat S; Kakria A; Devnani B; Wahi IK; Simson DK
    Rep Pract Oncol Radiother; 2017; 22(4):331-339. PubMed ID: 28663716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Re-irradiation for head and neck cancer: outcome and toxicity analysis using a prospective single institution database.
    Scolari C; Buchali A; Franzen A; Förster R; Windisch P; Bodis S; Zwahlen DR; Schröder C
    Front Oncol; 2023; 13():1175609. PubMed ID: 37456239
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Re-irradiation for head and neck squamous cell carcinoma.
    Benson R; Giridhar P; Venkatesulu BP; Mallick S; Raza MW; Rath GK
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):1-9. PubMed ID: 27595192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
    McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
    Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
    Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retrospective analysis of treatment outcomes following reirradiation in locoregionally recurrent head and neck cancer patients: A single institutional study.
    Kakria A; Rawat S; Bhutani R; Gupta G; Devnani B; Wahi IK; Ahlawat P
    Asia Pac J Clin Oncol; 2015 Jun; 11(2):129-34. PubMed ID: 25132076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.